[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Correction
May 12, 2004

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)—Correction

JAMA. 2004;291(18):2196. doi:10.1001/jama.291.18.2196

Investigator Omitted: In the Original Contribution entitled "Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)" published in the December 18, 2002, issue of THE JOURNAL (2002;288:2981-2997), Pasquale F. Nestico, MD, was inadvertently omitted from the list of ALLHAT investigators. His name should appear on page 2996 under "Pennsylvania."

×